This is exactly where Nader and the BOD is right now. Making the decision to sell under what they deem fair market value. Key here is what they deem fair market value. That is subjective as fair market value is what the market will bare. The licensing deals with upfront payments are vital to the advancement of BLA and Trials. Failure in making these deals is not an option at this juncture this close to the tipping point.
Lower the F#%*g bar and do whatever is necessary to get these deals done. It is hard for me to believe they can’t get $30M upfront.
As long as the HIV Mono and Cancer platforms are protected get on with it. I believe that is the exact dilemma Nader is facing right now. As we all know everything will change w $.
Market Data 
Markets 
